Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations From the 2018 AAOS/NIH U-13 Conference

Concern that misinformation from direct-to-consumer marketing of largely unproven “biologic” treatments such as platelet-rich plasma and cell-based therapies may erode the public trust and the responsible investment needed to bring legitimate biological therapies to patients have resulted in calls t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Acad Orthop Surg
Main Authors: Chu, Constance R., Rodeo, Scott, Bhutani, Nidhi, Goodrich, Laurie R., Huard, Johnny, Irrgang, James, LaPrade, Robert F., Lattermann, Christian, Lu, Ying, Mandelbaum, Bert, Mao, Jeremy, McIntyre, Louis, Mishra, Allan, Muschler, George F., Piuzzi, Nicolas S., Potter, Hollis, Spindler, Kurt, Tokish, John M., Tuan, Rocky, Zaslav, Kenneth, Maloney, William
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314629/
https://ncbi.nlm.nih.gov/pubmed/30300216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5435/JAAOS-D-18-00305
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados